Literature DB >> 17928576

What constitutes high quality of care for adults with epilepsy?

M J V Pugh1, D R Berlowitz, G Montouris, B Bokhour, J A Cramer, V Bohm, M Bollinger, S Helmers, A Ettinger, K J Meador, N Fountain, J Boggs, W O Tatum, J Knoefel, C Harden, R H Mattson, L Kazis.   

Abstract

BACKGROUND: Providers are increasingly being held accountable for the quality of care provided. While quality indicators have been used to benchmark the quality of care for a number of other disease states, no such measures are available for evaluating the quality of care provided to adults with epilepsy. In order to assess and improve quality of care, it is critical to develop valid quality indicators. Our objective is to describe the development of quality indicators for evaluating care of adults with epilepsy. As most care is provided in primary and general neurology care, we focused our assessment of quality on care within primary care and general neurology clinics.
METHODS: We reviewed existing national clinical guidelines and systematic reviews of the literature to develop an initial list of quality indicators; supplemented the list with indicators derived from patient focus groups; and convened a 10-member expert panel to rate the appropriateness, reliability, and necessity of each quality indicator.
RESULTS: From the original 37 evidence-based and 10 patient-based quality indicators, the panel identified 24 evidence-based and 5 patient-based indicators as appropriate indicators of quality. Of these, the panel identified 9 that were not necessary for high quality care.
CONCLUSION: There is, at best, a poor understanding of the quality of care provided for adults with epilepsy. These indicators, developed based on published evidence, expert opinion, and patient perceptions, provide a basis to assess and improve the quality of care for this population.

Entities:  

Mesh:

Year:  2007        PMID: 17928576     DOI: 10.1212/01.WNL.0000291947.29643.9f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Validity versus feasibility for quality of care indicators: expert panel results from the MI-Plus study.

Authors:  Adolfo Peña; Sandeep S Virk; Richard M Shewchuk; Jeroan J Allison; O Dale Williams; Catarina I Kiefe
Journal:  Int J Qual Health Care       Date:  2010-04-09       Impact factor: 2.038

2.  High health care costs in minority groups of older US Medicare beneficiaries with epilepsy.

Authors:  Maria Pisu; Joshua Richman; Jerzy P Szaflarski; Ellen Funkhouser; Chen Dai; Lucia Juarez; Edward Faught; Roy C Martin
Journal:  Epilepsia       Date:  2019-06-06       Impact factor: 5.864

3.  What does the U.S. Medicare administrative claims database tell us about initial antiepileptic drug treatment for older adults with new-onset epilepsy?

Authors:  Roy C Martin; Edward Faught; Jerzy P Szaflarski; Joshua Richman; Ellen Funkhouser; Kendra Piper; Lucia Juarez; Chen Dai; Maria Pisu
Journal:  Epilepsia       Date:  2017-02-07       Impact factor: 5.864

4.  Quality Indicator for Epilepsy Treatment 15 (QUIET-15): Intervening after recurrent seizures in the elderly.

Authors:  Jerzy P Szaflarski; Roy C Martin; Edward Faught; Ellen Funkhouser; Joshua Richman; Kendra Piper; Lucia Juarez; Chen Dai; Maria Pisu
Journal:  Epilepsy Behav       Date:  2017-04-12       Impact factor: 2.937

5.  Conceptualization and implementation of an interdisciplinary clinic for children with drug-resistant epilepsy during the COVID-19 pandemic.

Authors:  Debopam Samanta; Vimala Elumalai; Vidya C Desai; Megan Leigh Hoyt
Journal:  Epilepsy Behav       Date:  2021-10-29       Impact factor: 2.937

6.  Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis.

Authors:  Maria Pisu; Joshua Richman; Kendra Piper; Roy Martin; Ellen Funkhouser; Chen Dai; Lucia Juarez; Jerzy P Szaflarski; Edward Faught
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

7.  Quality indicators for multiple sclerosis.

Authors:  Eric M Cheng; Carolyn J Crandall; Christopher T Bever; Barbara Giesser; Jodie K Haselkorn; Ron D Hays; Paul Shekelle; Barbara G Vickrey
Journal:  Mult Scler       Date:  2010-06-18       Impact factor: 6.312

8.  Risk of pharmacokinetic interactions between antiepileptic and other drugs in older persons and factors associated with risk.

Authors:  Edward Faught; Jerzy P Szaflarski; Joshua Richman; Ellen Funkhouser; Roy C Martin; Kendra Piper; Chen Dai; Lucia Juarez; Maria Pisu
Journal:  Epilepsia       Date:  2018-02-07       Impact factor: 5.864

9.  Epilepsy care and mental health care for people with epilepsy: California Health Interview Survey, 2005.

Authors:  Alexander W Thompson; Rosemarie Kobau; Royce Park; David Grant
Journal:  Prev Chronic Dis       Date:  2012-02-23       Impact factor: 2.830

10.  The quality of care for adults with epilepsy: an initial glimpse using the QUIET measure.

Authors:  Mary Jo Pugh; Dan R Berlowitz; Jaya K Rao; Gabriel Shapiro; Ruzan Avetisyan; Amresh Hanchate; Kelli Jarrett; Jeffrey Tabares; Lewis E Kazis
Journal:  BMC Health Serv Res       Date:  2011-01-03       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.